STAVUDINE Safety Questions, STAVUDINE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about STAVUDINE. Our extensive database of STAVUDINE adverse events and STAVUDINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about STAVUDINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




STAVUDINE Safety Reports

Total STAVUDINE reports: 54.
STAVUDINE FDA safety alerts: 2001 2002 .
Reported deaths: 22    Reported hospitalizations: 11.
Take STAVUDINE Side Effects Survey or Share Your STAVUDINE Story. Read More Here.

Health Professional from UNITED STATES reported STAVUDINE problem on Nov 29, 2006. Male patient, 14 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: dialysis, disseminated intravascular coagulation, lactic acidosis, renal failure, thrombocytopenia. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE, FOSAMPRENAVIR CALCIUM. Patient died.

STAVUDINE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2007. Male patient, 50 years of age, weighting 116.0 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: pulmonary tuberculosis. STAVUDINE dosage: 40 MG BID PO. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, VITAMIN B6, TRIMETHOPRIM. Patient died on 12/17/2006.

Consumer or non-health professional from SOUTH AFRICA reported STAVUDINE problem on Jan 11, 2007. Female patient, child 11 years of age, was diagnosed with hiv infection, antifungal prophylaxis, tuberculosis and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, hepatomegaly, jaundice, vomiting. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, KALETRA, COTRIM D, RIFAMPICIN, PYRAZINAMIDE, ISONIAZID. Patient recovered.

STAVUDINE problem was reported by a Health Professional from UNITED STATES on Feb 02, 2007. Male patient, 56 years of age, weighting 160.9 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, nephropathy toxic. STAVUDINE dosage: unknown. During the same period patient was treated with TENOFOVIR, RITONAVIR, SAQUINAVIR. Patient recovered.

Health Professional from UNITED STATES reported STAVUDINE problem on Feb 02, 2007. Female patient, 30 years of age, weighting 97.00 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia. STAVUDINE dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, TENOFOVIR, RITONAVIR, LOPINAVIR, LAMIVUDINE. Patient died.

STAVUDINE problem was reported by a Consumer or non-health professional from BOTSWANA on Feb 05, 2007. Female patient, child 11 years of age, was diagnosed with hiv infection, antifungal prophylaxis, tuberculosis and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, pneumocystis jiroveci pneumonia. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, KALETRA, RIFAMPICIN, PYRAZINAMIDE, ISONIAZID. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported STAVUDINE problem on Mar 12, 2007. Female patient, 36 years of age, weighting 134.5 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. STAVUDINE dosage: 30MG BID PO. During the same period patient was treated with EFAVIRENZ, VITAMIN B CAP. Patient died.

STAVUDINE problem was reported by a Health Professional from UNITED STATES on Mar 12, 2007. Female patient, 42 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: aids related complication, gastroenteritis, hepatomegaly, isosporiasis, liver function test abnormal, nephropathy, weight decreased. STAVUDINE dosage: 30MG BID PO. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, BACTRIM, VIT B. Patient died.

Health Professional from ITALY reported STAVUDINE problem on Mar 22, 2007. Male patient, 13 years of age, was diagnosed with hiv infection, non-hodgkin's lymphoma and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus chorioretinitis, immune reconstitution syndrome, iridocyclitis, neutropenia, non-hodgkin's lymphoma. STAVUDINE dosage: unknown. During the same period patient was treated with METHOTREXATE, NEVIRAPINE, NELFINAVIR. Patient recovered.

STAVUDINE problem was reported by a Health Professional from ITALY on Mar 28, 2007. Female patient, 38 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, bone marrow toxicity, hepatic failure, hepatotoxicity, platelet count decreased, renal failure, stevens-johnson syndrome. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, LOPINAVIR, RITONAVIR, FLUCONAZOLE, ATOVAQUONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STAVUDINE problem on May 01, 2007. Male patient, 54 years of age, weighting 143.3 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: arthralgia, arthropod bite, joint swelling. STAVUDINE dosage: 30 MG TWICE DAILY PO. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, RIFAPENTINE, ISONIAZZID, ETHAMBUTOL HYDROCHLORIDE, VITAMIN B6, PROMETHAZINE, HYDROCHLOROTHIOZIDE. Patient died on 04/12/2007.

STAVUDINE problem was reported by a Health Professional from UNITED STATES on June 25, 2007. Female patient, 44 years of age, weighting 255.7 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, dialysis, lactic acidosis, upper respiratory tract infection, vomiting. STAVUDINE dosage: 40MG BID PO. During the same period patient was treated with LAMIVUDINE, LOPINAVIR, NIFEDIPINE, HYDROCHLORATHIAZIDE, GAVISCON, AUGMENTIN. Patient was hospitalized. Patient died on 06/06/2007.

Consumer or non-health professional from SOUTH AFRICA reported STAVUDINE problem on June 30, 2006. Male patient, 36 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: dehydration, hepatotoxicity. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, RIFAMPICIN, ISONIAZID. Patient was hospitalized. Patient died on 06/05/2006.

STAVUDINE problem was reported by a Health Professional from IRELAND on Jan 31, 2006. Male patient, 41 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis, renal failure. STAVUDINE dosage: unknown. Patient died.

Health Professional from BELGIUM reported STAVUDINE problem on Dec 27, 2002. Female patient, 45 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient died.

STAVUDINE problem was reported by a Health Professional from ESTONIA on May 31, 2004. Male patient, 51 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis, purulent pericarditis. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient died.

Health Professional from PORTUGAL reported STAVUDINE problem on Jan 31, 2006. Female patient, 64 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient died.

STAVUDINE problem was reported by a Health Professional from FRANCE on Jan 31, 2006. Male patient, 51 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute, hepatic encephalopathy, hepatic failure, hepatitis b virus, pancreatitis. STAVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, LAMIVUDINE, ABACAVIR, TENOFOVIR. Patient died.

Health Professional from POLAND reported STAVUDINE problem on July 03, 2006. Female patient, 27 years of age, weighting 147.7 lb, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: basedow's disease. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, AMPRENAVIR, RITONAVIR. Patient recovered.

STAVUDINE problem was reported by a Physician from PORTUGAL on June 19, 2006. Female patient, 65 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: malignant palate neoplasm. STAVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.

Physician from PORTUGAL reported STAVUDINE problem on June 19, 2006. Female patient, 65 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: malignant palate neoplasm. STAVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.

STAVUDINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 30, 2005. Male patient, 41 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, pain in extremity, pancreatitis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, TENOFOVIR. Patient recovered.

Health Professional from CANADA reported STAVUDINE problem on Aug 21, 2006. Female patient, 47 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatic steatosis, lactic acidosis, mitochondrial dna depletion. STAVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, NEVIRAPINE, BENZATROPINE, LOXAPINE. Patient was hospitalized. Patient died.

STAVUDINE problem was reported by a Health Professional from FRANCE on Aug 18, 2006. Male patient, 60 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: progressive multifocal leukoencephalopathy. STAVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, TENOFOVIR. Patient was hospitalized. Patient died.

Health Professional from CANADA reported STAVUDINE problem on Aug 18, 2006. Female patient, 47 years of age, was diagnosed with pneumonia and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis, metabolic disorder. STAVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, NEVIRAPINE, BENZTROPINE MESYLATE, LOXAPINE. Patient was hospitalized. Patient died.

STAVUDINE problem was reported by a Health Professional from CANADA on Aug 18, 2006. Female patient, 47 years of age, was diagnosed with pneumonia and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis, metabolic disorder. STAVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, NEVIRAPINE, BENZTROPINE MESYLATE, LOXAPINE. Patient was hospitalized. Patient died.

Health Professional from UNITED STATES reported STAVUDINE problem on Sept 01, 2006. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. STAVUDINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

STAVUDINE problem was reported by a Health Professional from UNITED KINGDOM on Aug 30, 2006. Female patient, weighting 6.61 lb, was diagnosed with prophylaxis against hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: precocious puberty. STAVUDINE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported STAVUDINE problem on Sept 01, 2006. Male patient, child 8 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: sepsis, stevens-johnson syndrome. STAVUDINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, LAMIVUDINE. Patient was hospitalized. Patient died.

STAVUDINE problem was reported by a Health Professional from FRANCE on Sept 12, 2006. Male patient, 39 years of age, was diagnosed with pulmonary hypertension and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: hyperlactacidaemia, pancytopenia, pulmonary hypertension. STAVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, CRIXIVAN, TRACLEER, PENTAMIDINE AEROSOL, PYRIMETHAMINE, CLINDAMYCIN. Patient recovered.

Health Professional from SOUTH AFRICA reported STAVUDINE problem on Oct 06, 2006. Female patient, 36 years of age, weighting 286.6 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, VITAMINS. Patient was hospitalized. Patient died.

STAVUDINE problem was reported by a Pharmacist from UNITED STATES on Oct 17, 2006. Male patient, 66 years of age, weighting 188.5 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal pain upper, abscess, blood pressure increased, chills, condition aggravated, cough, decreased appetite, diarrhoea. STAVUDINE dosage: 40MG BID PO. Patient was hospitalized. Patient recovered.

Health Professional from SOUTH AFRICA reported STAVUDINE problem on Oct 12, 2006. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

STAVUDINE problem was reported by a Health Professional from SOUTH AFRICA on Oct 12, 2006. Female patient, 36 years of age, weighting 127.9 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

Health Professional from SOUTH AFRICA reported STAVUDINE problem on Oct 12, 2006. Female patient, 39 years of age, weighting 213.8 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient died.

STAVUDINE problem was reported by a Health Professional from SOUTH AFRICA on Sept 27, 2006. Female patient, 35 years of age, weighting 180.8 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient died.

Health Professional from SOUTH AFRICA reported STAVUDINE problem on Oct 12, 2006. Female patient, 35 years of age, weighting 125.7 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

STAVUDINE problem was reported by a Health Professional from SOUTH AFRICA on Oct 12, 2006. Female patient, 34 years of age, weighting 180.8 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

Health Professional from SOUTH AFRICA reported STAVUDINE problem on Oct 12, 2006. Female patient, 32 years of age, weighting 147.7 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

STAVUDINE problem was reported by a Health Professional from SOUTH AFRICA on Oct 12, 2006. Female patient, 35 years of age, weighting 183.0 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

Health Professional from SOUTH AFRICA reported STAVUDINE problem on Oct 12, 2006. Female patient, 37 years of age, weighting 308.6 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

STAVUDINE problem was reported by a Health Professional from SOUTH AFRICA on Oct 12, 2006. Female patient, 37 years of age, weighting 227.1 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient died.

Health Professional from SOUTH AFRICA reported STAVUDINE problem on Oct 12, 2006. Female patient, 36 years of age, weighting 154.3 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

STAVUDINE problem was reported by a Health Professional from SOUTH AFRICA on Oct 12, 2006. Female patient, 55 years of age, weighting 174.2 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: lactic acidosis. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE. Patient recovered.

Health Professional from ITALY reported STAVUDINE problem on Oct 18, 2006. Male patient, 58 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: bladder cancer. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, SAQUINAVIR. Patient recovered.

STAVUDINE problem was reported by a Physician from JAPAN on Oct 20, 2006. Female patient, 62 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: sick sinus syndrome. STAVUDINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, LOPINAVIR. Patient recovered.

Health Professional from UNITED STATES reported STAVUDINE problem on Nov 29, 2006. Female patient, 21 years of age, weighting 121.3 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, gastroenteritis cryptosporidial, immunosuppression, isosporiasis, vomiting, weight decreased. STAVUDINE dosage: 30 MG BID PO. During the same period patient was treated with LAMIVUDINE, EFAVIRENZ, BACTRIM. Patient died on 09/23/2006.

STAVUDINE problem was reported by a Health Professional from SOUTH AFRICA on Dec 06, 2006. Female patient, 54 years of age, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: hypercholesterolaemia, hypertension, lipodystrophy acquired. STAVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, BENDROFLUMETHIAZIDE, ATENOLOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported STAVUDINE problem on July 02, 2007. Female patient, 24 years of age, weighting 156.5 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, lower respiratory tract infection, stillbirth. STAVUDINE dosage: 40 MG TWICE A DAY ORAL. During the same period patient was treated with LAMIVUDINE, LOPINAVIR, COTRIM, FOLATE, VITAMIN B. Patient recovered.

STAVUDINE problem was reported by a Health Professional from BRAZIL on Aug 03, 2007. Male patient, 34 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: dyslipidaemia, hepatic steatosis. STAVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, EFAVIRENZ, ZIDOVUDINE, LAMIVUDINE, LOPINAVIR, RITONAVIR. Patient recovered.

Health Professional from UNITED STATES reported STAVUDINE problem on Aug 15, 2007. Female patient, 24 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. STAVUDINE dosage: unknown. Patient recovered.

STAVUDINE problem was reported by a Health Professional from UNITED STATES on Aug 15, 2007. Female patient, 34 years of age, was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. STAVUDINE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported STAVUDINE problem on Sept 10, 2007. Female patient, weighting 6.61 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: joint dislocation, pregnancy. STAVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE. Patient recovered.

STAVUDINE problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient, weighting 6.61 lb, was diagnosed with hiv infection and was treated with STAVUDINE. After drug was administered, patient experienced the following problems/side effects: joint dislocation, pregnancy. STAVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE. Patient recovered.

Ask Our Patient Community about STAVUDINE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)